Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Chaput

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Journal of Hepatology|April 3, 2001
Intratumoral production of interleukin-5 leading to paraneoplastic peripheral eosinophilia in hepatocellular carcinomaA Balian, E Bonte, S Naveau, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1987
Reduction of the observed prevalence of so-called non-A non-B hepatitis using sensitive markers of HBV and herpes viruses infectionsT Poynard, J F Delfraissy, S Naveau, et al.
European Journal of Pharmacology|September 3, 1998
In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effectM Bardou, B Dousset, C Deneux-Tharaux, et al.
Hepatology (Baltimore, Md.)|May 1, 1987
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleedingT Poynard, D Lebrec, P Hillon, et al.
Journal of Hepatology|June 13, 1998
Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severityS Naveau, D Emilie, A Balian, et al.
Digestion|January 1, 1977
Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter studyA Gerolami, H Sarles, R Brette, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1989
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patientsP Bedossa, T Poynard, A Abella, et al.
Gastroenterology|June 1, 1996
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneP Mathurin, V Duchatelle, M J Ramond, et al.
Therapie|July 1, 1977
[Multicenter study of the effect of different doses of chenodeoxycholic acid in cholesterol biliary lithiasis (proceedings)]C Bermann, R Brette, J C Chaput, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinomaP Mathurin, B Raynard, S Dharancy, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Journal of Hepatology|April 3, 2001
Intratumoral production of interleukin-5 leading to paraneoplastic peripheral eosinophilia in hepatocellular carcinomaA Balian, E Bonte, S Naveau, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1987
Reduction of the observed prevalence of so-called non-A non-B hepatitis using sensitive markers of HBV and herpes viruses infectionsT Poynard, J F Delfraissy, S Naveau, et al.
European Journal of Pharmacology|September 3, 1998
In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effectM Bardou, B Dousset, C Deneux-Tharaux, et al.
Hepatology (Baltimore, Md.)|May 1, 1987
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleedingT Poynard, D Lebrec, P Hillon, et al.
Journal of Hepatology|June 13, 1998
Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severityS Naveau, D Emilie, A Balian, et al.
Digestion|January 1, 1977
Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter studyA Gerolami, H Sarles, R Brette, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1989
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patientsP Bedossa, T Poynard, A Abella, et al.
Gastroenterology|June 1, 1996
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneP Mathurin, V Duchatelle, M J Ramond, et al.
Therapie|July 1, 1977
[Multicenter study of the effect of different doses of chenodeoxycholic acid in cholesterol biliary lithiasis (proceedings)]C Bermann, R Brette, J C Chaput, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinomaP Mathurin, B Raynard, S Dharancy, et al.
Pageof 20